Alpine Immune Sciences, Inc. (ALPN) Financials

ALPN Assets vs Liabilities
DateAssetsLiabilities
March 31, 2024 373.6 million 40.9 million
Dec. 31, 2023 381.8 million 53.9 million
Sept. 30, 2023 240.5 million 78.9 million
June 30, 2023 252.8 million 83.4 million

ALPN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2024 -27.7 million 4.0 million
Dec. 31, 2023 -19.1 million 2.8 million
Sept. 30, 2023 -15.8 million 2.7 million
June 30, 2023 -18.4 million 2.6 million

ALPN Net Income

No data available :(

ALPN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2024 305.7 million 8.7 million 8.7 million
Dec. 31, 2023 327.4 million 9.0 million 9.0 million
Sept. 30, 2023 193.5 million 9.3 million 10.2 million
June 30, 2023 203.8 million 9.6 million 10.4 million

ALPN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2024 64.0 million
Dec. 31, 2023 60.3 million
Sept. 30, 2023 49.2 million
June 30, 2023 48.0 million

ALPN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2024 19000 22.3 million 7.3 million -
Dec. 31, 2023 114000 22.8 million 6.4 million -
Sept. 30, 2023 1000 19.2 million 5.4 million -
June 30, 2023 279000 19.2 million 5.0 million -

ALPN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2024 7.0 million 147000
Dec. 31, 2023 30.9 million 148000
Sept. 30, 2023 10.0 million 146000
June 30, 2023 8.6 million 142000

ALPN Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ALPN

Price: $64.97

52 week price:
7.71
64.97

Earnings Per Share: -0.64 USD

P/E Ratio: -22.30

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 35394

Ebitda: 2.3 million

Market Capitalization: 4.5 billion

Links: